Following initial puncture with the cystotome (27-gauge needle), a 6.0 mm in diameter continuous curvilinear capsulorrhexis (CCC) was performed using a capsule forceps. Eyes with incomplete or largely decentered CCC, in which capsule stabilization devices could not be inserted or hooked, were excluded from the experiment. When CCC could not be performed because of severe lens movement in models with large zonular dehiscence, highly retentive and cohesive OVD (Healon5
; Abbot Medical Optics, Inc., IL, USA) was injected into the anterior chamber. Capsule stabilization devices, specifically CTR (CTR130A0; Hoya Surgical Optics, Chino Hills, CA, USA), IR (Grieshaber Iris Retractor; Alcon Laboratories, Ft. Worth, TX, USA), or CE (Handaya Co., Ltd, Tokyo, Japan), were introduced. The numbers of CTRs, IRs, and CEs used in the models with different degrees of zonular dehiscence are shown in
Table 1. The CTR was inserted in the capsular bag using an injector (Capsule tension ring injector; Geuder, G-32960; M.E. Technica, Tokyo, Japan). Equally spaced IRs were inserted in the area of zonular dehiscence under the anterior capsulorrhexis rim and the capsule was temporarily fixed to the scleral wall by adjusting the silicon rubber ring. We developed a CE to preserve the lens capsule integrity during PEA in eyes with weak zonules.
8 The CE is flexible, 10.0 mm long, and fashioned from 5-0 polypropylene. The CE is shaped like an IR, but the contact portion is bent at 1.25 mm, with an end bifurcating to form a 2.0-mm T-shaped footpad (
Fig. 2A). The CE simultaneously expands the capsular equator and the edge of the CCC by a T-shaped footpad (
Fig. 2B). The CE was spaced equally in the area of zonular dehiscence, with the T-shaped end passing around the anterior capsular flap to fit the curvature of the equator, and the capsule was temporarily fixed to the scleral wall by adjusting the silicon rubber ring.